Trial Profile
Single-dose and Steady-state Pharmacokinetics of BIA 5-453 and Its Metabolites in Healthy Male Elderly Subjects Compared With Those in Healthy Male Young Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Chronic heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Bial
- 29 Mar 2017 New trial record